Brivaracetam Oral Solution
Product Images NDC 67877-904

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Brivaracetam Oral Solution (NDC 67877-904). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Briva-10mg-per-ml-cart-label-a (Briva 10mg Per mL Cart Label A)

This is a description of Brivaracetam Oral Solution, containing 10 mg of brivaracetam per mL. The usual dosage and storage instructions are provided. It is manufactured by Alkem Laboratories Ltd. in India and distributed by Ascend Laboratories LLC in New Jersey, USA. The medication guide should be dispensed to each patient, and the product should be discarded after 5 months of opening the bottle. Keep out of reach of children.*

FDA Label Image

Briva-10mg-per-ml-cont-label-a1 (Briva 10mg Per mL Cont Label A1)

Each mL of the product contains 10 mg of brivaracetam. The NDC number is 67677-904-58. This medication is an oral solution and should be stored at room temperature between 15°C to 30°C. It must not be frozen. Any unused portion should be discarded after 5 months of opening. The product should be dispensed with the accompanying Medication Guide to each patient. Manufactured by Alkem Laboratories Ltd. in Mumbai, India, and distributed by Ascend Laboratories, LLC in Bedminster, NJ. Keep out of the reach of children.*

FDA Label Image

Briva-fig-1 (Briva Fig 1)

This text provides information about the reduction in seizure frequency from baseline for patients receiving different treatments. The data includes the proportion of patients in various categories and the percentage reduction in seizure frequency for Placebo, Olx:as4, and Brivaracetam Oral Solution at different dosages. The details of Brivaracetam Oral Solution at 100mg/day and 50mg/day for a group of 249 patients are also presented.*

FDA Label Image

Briva-str (Briva Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.